Metformin use, compared with no use, was associated with a lower risk for uterine fibroids among women with diabetes.

Among the benefits of semaglutide, the GLP-1 receptor agonist may protect against heart failure events in patients with type 2 diabetes and CKD.

There are clinical benefits up to 1 year following endovascular thrombectomy for treatment of acute basilar artery occlusion.

Normoglycemic individuals spent 87% of their daily time in in the “tight range” of glucose levels (70-140 mg/dL) and the remainder above 140 mg/dL.

Comorbid diabetes was linked to worse functional and mortality outcomes, including maximum oxygen consumption, among patients with heart failure.

There is increased risk of developing hypertension in patients with self-reported snoring and excessive daytime sleepiness.

Surgeries are generally safe but cumulatively are associated with cognitive decline and neurodegeneration, according to a study published in the September issue of The Lancet Healthy Longevity.

A study has found that there is a higher prevalence of congenital heart defects and comorbidity burden in Colorado than previously estimated.

Hospitalization for COVID-19 represents a coronary artery disease risk equivalent, contributing to an increased risk for MACE.

SGLT-2 inhibitors were associated with the lowest risk for incidental dementia relative to DPP-4 inhibitors and GLP-1RAs in type 2 diabetes.

Reduced AMR proportions were noted for multiple pathogens from 2007 to 2019, but some previously declining trends have reversed course since the COVID-19 pandemic.

Patients are at risk for worse cognition and greater cognitive decline during midlife if they have history of gestational hypertension ...